A new Era in
Cellular Reprogramming
Safer, precise and more effective
IN-VIVO • CELL-TARGETED • PROTEIN-BASED • NON-INTEGRATIVE
IN-vivo & cell-TArgeted

Reprograming an individual's own cells within their body for safer and more natural interventions.

Our in vivo engineering platform enables precise and efficient delivery of therapeutic molecules to specific cell types, adaptable across a range of medical applications. We provide flexible solutions to address diverse clinical needs with safety and precision.

NON-VIRAL and HUMAN-BASED

Highly personalized and less intrusive treatments

Our innovative non-viral platform ensures that our interventions are perfectly synchronized with human physiology for unmatched effectiveness and safety, reshaping the way to approach health. 

NON-INtegrative

We do not alter your cells. We teach them how to restore proper function or adapt to specific needs.

Our platform does not integrate new genes in your genome; instead, our approach focuses on transient cell modulation without causing permanent genetic alterations. By delivering precise therapeutic instructions, we reprogram cells to restore proper function or adapt to specific needs. This temporary and reversible method ensures safety while enabling cells to perform optimally, addressing a wide range of clinical challenges with flexibility and precision.

A New Era
in Cellular Health

At DNAmic, we are pioneering the future of cellular reprogramming with our state-of-the-art platform. Our platform is underpinned by advanced self-assembling structures, meticulously designed to transport therapeutic molecules directly to the cells that need them most, reprogramming them to restore proper function or adapt to specific needs..

Self-assembling structures designed to transport therapeutic molecules directly to the cells that need them most, reprogramming them into a healthier and youthful state.

Core
Precision Delivery with Self-Assembling Proteins
The DNAmic platform utilizes reprogrammed proteins that encapsulate and safeguard therapeutic molecules, ensuring they reach their target cells without compromise. This targeted approach enables a new level of precision in cellular therapy
Reprogrammed proteins that encapsulate and safeguard therapeutic molecules.
Unmatched Biocompatibility
Crafted from human proteins that seamlessly integrate with human biology, our platform is engineered to reduce immune responses and adverse reactions.
Crafted from human proteins that seamlessly integrate with human biology.
Cargo
Safe and Transient
The cornerstone of our approach lies in the transient modification of cellular behavior—without altering the DNA. This ensures the utmost safety and reversibility of our treatments, paving the way for a new standard in therapeutic interventions.
Transient modification of cellular behavior—without altering the DNA.
Expansive Therapeutic Horizons
Capable of carrying various therapeutic molecules — including nucleic acids and proteins — the DNAmic platform offers a broad spectrum of applications. This versatility positions us at the forefront of cellular engineering and regenerative medicine.
Capable of carrying various therapeutic molecules offering a broad spectrum of applications.
Envelope
Sophisticated Targeting System
By customizing the surface of our DNAmic structures with specific ligands, we achieve unparalleled accuracy in delivering treatments directly to the affected cell types, tissues, and organs, enhancing therapeutic outcomes while minimizing side effects.
Unparalleled accuracy in delivering treatments directly to the affected cell types, tissues, and organs.
Optimized Cellular Uptake
Our structures are endowed with unique properties that enhance their absorption by target cells, ensuring that therapeutic agents are not just delivered but are also effectively utilized by the body, maximizing their healing potential.
Our structures are endowed with unique properties that enhance their absorption by target cells.

"In a field where precision is paramount and safety non-negotiable, DNAmic platform is not just an alternative; it is the solution that will redefine the landscape of cellular therapy and regenerative medicine."

Jesus Beltran, PhD.

CSO and CO-Founder DNamic

@ 2024 DNAmic BioSystems